ATX-MS-1467 in Multiple Sclerosis
NCT01973491
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
ATX-MS-1467
Sponsor
Merck KGaA, Darmstadt, Germany